These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34522901)

  • 41. Indel detection from DNA and RNA sequencing data with transIndel.
    Yang R; Van Etten JL; Dehm SM
    BMC Genomics; 2018 Apr; 19(1):270. PubMed ID: 29673323
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Single-Cell Isolation from Regenerating Murine Muscles for RNA-Sequencing Analysis.
    Oprescu SN; Yue F; Kuang S
    STAR Protoc; 2020 Sep; 1(2):100051. PubMed ID: 33111097
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analytical protocol to identify local ancestry-associated molecular features in cancer.
    Carrot-Zhang J; Han S; Zhou W; Damrauer JS; Kemal A; ; Cherniack AD; Beroukhim R
    STAR Protoc; 2021 Dec; 2(4):100766. PubMed ID: 34585150
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determining Alternative Protein Isoform Expression Using RNA Sequencing and Mass Spectrometry.
    Han Y; Wright JM; Lau E; Lam MPY
    STAR Protoc; 2020 Dec; 1(3):100138. PubMed ID: 33377032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neoantigen landscape in metastatic nasopharyngeal carcinoma.
    Lin M; Zhang XL; You R; Yang Q; Zou X; Yu K; Liu YP; Zou RH; Hua YJ; Huang PY; Wang J; Zhao Q; Jiang XB; Tang J; Gu YK; Yu T; He GP; Xie YL; Wang ZQ; Liu T; Chen SY; Zuo ZX; Chen MY
    Theranostics; 2021; 11(13):6427-6444. PubMed ID: 33995666
    [No Abstract]   [Full Text] [Related]  

  • 46. Proteogenomic Platform for Identification of Tumor Specific Antigens.
    Faktor J; Hernychová L; Vojtěšek B; Hupp T
    Klin Onkol; 2018; 31(Suppl 2):102-107. PubMed ID: 31023032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathway-guided analysis identifies Myc-dependent alternative pre-mRNA splicing in aggressive prostate cancers.
    Phillips JW; Pan Y; Tsai BL; Xie Z; Demirdjian L; Xiao W; Yang HT; Zhang Y; Lin CH; Cheng D; Hu Q; Liu S; Black DL; Witte ON; Xing Y
    Proc Natl Acad Sci U S A; 2020 Mar; 117(10):5269-5279. PubMed ID: 32086391
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evolving neoantigen profiles in colorectal cancers with DNA repair defects.
    Rospo G; Lorenzato A; Amirouchene-Angelozzi N; Magrì A; Cancelliere C; Corti G; Negrino C; Amodio V; Montone M; Bartolini A; Barault L; Novara L; Isella C; Medico E; Bertotti A; Trusolino L; Germano G; Di Nicolantonio F; Bardelli A
    Genome Med; 2019 Jun; 11(1):42. PubMed ID: 31253177
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimized workflow for single-cell transcriptomics on infectious diseases including COVID-19.
    De Domenico E; Bonaguro L; Schulte-Schrepping J; Becker M; Händler K; Schultze JL
    STAR Protoc; 2020 Dec; 1(3):100233. PubMed ID: 33377120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TimiGP: An R package to depict the tumor microenvironment from bulk transcriptomics.
    Li C; Zhang J; Cheng C
    STAR Protoc; 2023 Dec; 4(4):102742. PubMed ID: 38019649
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Strength in Numbers: Identifying Neoantigen Targets for Cancer Immunotherapy.
    Kishton RJ; Lynn RC; Restifo NP
    Cell; 2020 Oct; 183(3):591-593. PubMed ID: 33125888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A protocol to extract cell-type-specific signatures from differentially expressed genes in bulk-tissue RNA-seq.
    Marquez-Galera A; de la Prida LM; Lopez-Atalaya JP
    STAR Protoc; 2022 Mar; 3(1):101121. PubMed ID: 35118429
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protocol for post-processing of bacterial pangenome data using Pagoo pipeline.
    Ferrés I; Iraola G
    STAR Protoc; 2021 Dec; 2(4):100802. PubMed ID: 34632414
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A proteogenomic approach to target neoantigens in solid tumors.
    Verma A; Halder A; Marathe S; Purwar R; Srivastava S
    Expert Rev Proteomics; 2020; 17(11-12):797-812. PubMed ID: 33491499
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CapZyme-Seq: A 5'-RNA-Seq Method for Differential Detection and Quantitation of NAD-Capped and Uncapped 5'-Triphosphate RNA.
    Vvedenskaya IO; Nickels BE
    STAR Protoc; 2020 Jun; 1(1):. PubMed ID: 32719830
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TruNeo: an integrated pipeline improves personalized true tumor neoantigen identification.
    Tang Y; Wang Y; Wang J; Li M; Peng L; Wei G; Zhang Y; Li J; Gao Z
    BMC Bioinformatics; 2020 Nov; 21(1):532. PubMed ID: 33208106
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protocol for integrated analysis of bacterial RNA-seq and ChIP-seq data for establishing a co-expression network.
    Ding Y; Li J; Li T; Deng X
    STAR Protoc; 2023 May; 4(2):102322. PubMed ID: 37210720
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduced Neoantigen Expression Revealed by Longitudinal Multiomics as a Possible Immune Evasion Mechanism in Glioma.
    Nejo T; Matsushita H; Karasaki T; Nomura M; Saito K; Tanaka S; Takayanagi S; Hana T; Takahashi S; Kitagawa Y; Koike T; Kobayashi Y; Nagae G; Yamamoto S; Ueda H; Tatsuno K; Narita Y; Nagane M; Ueki K; Nishikawa R; Aburatani H; Mukasa A; Saito N; Kakimi K
    Cancer Immunol Res; 2019 Jul; 7(7):1148-1161. PubMed ID: 31088845
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Generation of Sequencing Libraries for Structural Analysis of Bacterial 5' UTRs.
    Ignatov D; Vaitkevicius K; Johansson J
    STAR Protoc; 2020 Sep; 1(2):100046. PubMed ID: 33111092
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protocol to assess fatal embolism risks from human stem cells.
    Ma F; Zhang J; Jin X; Han P; Liu Y; Zhang T; Yan K; Kang YJ
    STAR Protoc; 2023 May; 4(2):102268. PubMed ID: 37133989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.